Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |